April 6, 2026
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today an update related to: Intratubal insemination success, at age 39 – Aslyn’s story.
